Buyout Of Tourmaline By Novartis Primarily On Pacibekitug IL

Novartis AG acquires Tourmaline Bio, Inc. for $1.4B to boost its cardiovascular pipeline with pacibekitug. Click here for more on NVS and TRML stocks.